Niagen Bioscience, Inc. — Director's Dealing 2020

Nov 6, 2020

SEC Form 4/A — Form 4/A

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2020-02-25

Reporting Person: Jaksch Frank L Jr (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-25	Employee Stock Options (right to buy)	$3.27	A	74048	Acquired	2030-02-25	Common Stock (74048)	Direct

Footnotes

F1: This Form 4 Amendment is being filed solely to add the Power of Attorney.

F2: Options vest 33% on February 25, 2021 and thereafter 1/36th vest each month.